Funding Tracker/Galvanize Therapeutics

Series D · Medical Devices · United States

Galvanize Therapeutics raises $130M

Announced November 16, 2026

The round

Galvanize Therapeutics announced a Series D round of $130M on November 16, 2026, led by HealthQuest Capital. Other participants include Olympus Innovation Ventures, Braidwell LP, Sofinnova Partners, Norwest, Elevage Medical Technologies, Ally Bridge Group, Perceptive Advisors, Janus Henderson Investors, Longaeva Partners, Fidelity Management & Research Company, T. Rowe Price Associates, Inc..

The SignalGalvanize Therapeutics announced an oversubscribed $130 million Series D led by HealthQuest Capital to expand commercial use of its Aliya pulsed electric field ablation platform, generate clinical evidence, advance RheOx therapy for chronic bronchitis and develop next-generation PEF products.

Galvanize Therapeutics logo

What Galvanize Therapeutics does

Commercial-stage medtech company pioneering pulsed electric field ablation for oncology and chronic disease.

Galvanize Therapeutics is a commercial-stage medical technology company pioneering pulsed electric field (PEF) ablation technologies for oncology and chronic disease. It is commercializing the Aliya PEF platform in the United States and advancing a pipeline that includes RheOx therapy for chronic bronchitis. On November 16, 2026, the company announced an oversubscribed $130 million Series D led by HealthQuest Capital, with Olympus Innovation Ventures and Braidwell LP joining as new investors. Proceeds will support continued commercial expansion of Aliya, clinical evidence generation, advancement of RheOx therapy for chronic bronchitis, and development of next-generation PEF products and platforms.

Full Galvanize Therapeutics profile
Amount
$130M
Stage
Series D
Announced
November 16, 2026
Led by
HealthQuest Capital
Other investors
Olympus Innovation Ventures, Braidwell LP, Sofinnova Partners, Norwest, Elevage Medical Technologies, Ally Bridge Group, Perceptive Advisors, Janus Henderson Investors, Longaeva Partners, Fidelity Management & Research Company, T. Rowe Price Associates, Inc.
Vertical
Medical Devices
Country
United States
Headquarters
Redwood City, CA, United States